| Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data VHJ Van der Velden, G Cazzaniga, A Schrauder, J Hancock, P Bader, ... Leukemia 21 (4), 604-611, 2007 | 878 | 2007 |
| The MLL recombinome of acute leukemias in 2017 C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284, 2018 | 716 | 2018 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 578 | 2013 |
| New insights to the MLL recombinome of acute leukemias C Meyer, E Kowarz, J Hofmann, A Renneville, J Zuna, J Trka, ... Leukemia 23 (8), 1490-1499, 2009 | 521 | 2009 |
| Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia P Theunissen, E Mejstrikova, L Sedek, AJ van der Sluijs-Gelling, G Gaipa, ... Blood, The Journal of the American Society of Hematology 129 (3), 347-357, 2017 | 417 | 2017 |
| Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002 J Stary, M Zimmermann, M Campbell, L Castillo, E Dibar, S Donska, ... Journal of clinical oncology 32 (3), 174-184, 2014 | 414 | 2014 |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 405 | 2008 |
| NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern IHIM Hollink, MM van den Heuvel-Eibrink, ST Arentsen-Peters, ... Blood, The Journal of the American Society of Hematology 118 (13), 3645-3656, 2011 | 345 | 2011 |
| Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21 L Rainis, D Bercovich, S Strehl, A Teigler-Schlegel, B Stark, J Trka, ... Blood 102 (3), 981-986, 2003 | 323 | 2003 |
| The MLL recombinome of acute leukemias C Meyer, B Schneider, S Jakob, S Strehl, A Attarbaschi, S Schnittger, ... Leukemia 20 (5), 777-784, 2006 | 285 | 2006 |
| Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a … M Brüggemann, M Kotrova, H Knecht, J Bartram, M Boudjogrha, V Bystry, ... Leukemia 33 (9), 2241-2253, 2019 | 251 | 2019 |
| IKZF1 status as a prognostic feature in BCR-ABL1–positive childhood ALL A Van Der Veer, M Zaliova, F Mottadelli, P De Lorenzo, G Te Kronnie, ... Blood, The Journal of the American Society of Hematology 123 (11), 1691-1698, 2014 | 184 | 2014 |
| BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations A Basak, M Hancarova, JC Ulirsch, TB Balci, M Trkova, M Pelisek, ... The Journal of clinical investigation 125 (6), 2363-2368, 2015 | 169 | 2015 |
| NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern JDE de Rooij, IHIM Hollink, S Arentsen-Peters, JF Van Galen, ... Leukemia 27 (12), 2280-2288, 2013 | 164 | 2013 |
| Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia IHIM Hollink, MM van den Heuvel-Eibrink, M Zimmermann, BV Balgobind, ... Blood, The Journal of the American Society of Hematology 113 (23), 5951-5960, 2009 | 163 | 2009 |
| Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by … J Trka, M Kalinova, O Hrušák, J Zuna, O Krejčí, J Madžo, P Sedláček, ... Leukemia 16 (7), 1381-1389, 2002 | 151 | 2002 |
| Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia E Ellinghaus, M Stanulla, G Richter, D Ellinghaus, G Te Kronnie, G Cario, ... Leukemia 26 (5), 902-909, 2012 | 137 | 2012 |
| Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53 N Gefen, V Binder, M Zaliova, Y Linka, M Morrow, A Novosel, L Edry, ... Leukemia 24 (1), 89-96, 2010 | 136 | 2010 |
| Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease … L Boublikova, M Kalinova, J Ryan, F Quinn, A O'Marcaigh, O Smith, ... Leukemia 20 (2), 254-263, 2006 | 132 | 2006 |
| Detection of prognostically relevant genetic abnormalities in childhood B‐cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee … CJ Harrison, O Haas, J Harbott, A Biondi, M Stanulla, J Trka, S Izraeli British journal of haematology 151 (2), 132-142, 2010 | 129 | 2010 |
